PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 67 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $643,000 | 0.0% | 91,144 | 0.0% | 0.02% | +66.7% |
| Q4 2019 | $643,000 | -41.3% | 91,144 | 0.0% | 0.01% | -40.0% |
| Q3 2019 | $1,095,000 | -0.8% | 91,144 | 0.0% | 0.02% | +7.1% |
| Q2 2019 | $1,104,000 | -27.7% | 91,144 | -24.9% | 0.01% | -26.3% |
| Q1 2019 | $1,526,000 | +164.9% | 121,400 | +41.8% | 0.02% | +137.5% |
| Q4 2018 | $576,000 | -34.6% | 85,600 | 0.0% | 0.01% | -11.1% |
| Q3 2018 | $881,000 | +159.1% | 85,600 | +69.2% | 0.01% | +200.0% |
| Q2 2018 | $340,000 | +1.5% | 50,600 | +29.7% | 0.00% | -25.0% |
| Q1 2018 | $335,000 | -58.7% | 39,000 | 0.0% | 0.00% | -55.6% |
| Q4 2017 | $811,000 | +17.7% | 39,000 | 0.0% | 0.01% | +12.5% |
| Q3 2017 | $689,000 | – | 39,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |